{"id":"https://openalex.org/W4382645238","doi":null,"title":"Preclinical evaluation of recombinant human IFN\u03b12b-containing magnetoliposomes for treating hepatocellular carcinoma","display_name":"Preclinical evaluation of recombinant human IFN\u03b12b-containing magnetoliposomes for treating hepatocellular carcinoma","publication_year":2014,"publication_date":"2014-09-01","ids":{"openalex":"https://openalex.org/W4382645238"},"language":"en","primary_location":{"id":"pmh:oai:dovepress.com/18511","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/preclinical-evaluation-of-recombinant-human-ifnalpha2b-containing-magn-peer-reviewed-article-IJN","pdf_url":"https://www.dovepress.com/preclinical-evaluation-of-recombinant-human-ifnalpha2b-containing-magn-peer-reviewed-article-IJN","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.dovepress.com/preclinical-evaluation-of-recombinant-human-ifnalpha2b-containing-magn-peer-reviewed-article-IJN","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012668645","display_name":"Haopeng Ye","orcid":"https://orcid.org/0009-0004-0670-9341","observed_orcids":["https://orcid.org/0009-0004-0670-9341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ye H","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092364474","display_name":"Tong JS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tong JS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062597596","display_name":"Wu Jz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wu JZ","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100451924","display_name":"Xun Xu","orcid":"https://orcid.org/0000-0002-4246-4343","observed_orcids":["https://orcid.org/0000-0002-4246-4343","https://orcid.org/0009-0005-0170-8339"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xu X","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057335200","display_name":"Wu Sj","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wu SJ","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057883442","display_name":"Tan Bt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tan BT","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092364475","display_name":"Shi MJ","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shi MJ","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103589145","display_name":"Wang Jg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wang JG","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092364476","display_name":"Zhao WB","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhao WB","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073378831","display_name":"H Jiang","orcid":"https://orcid.org/0000-0002-5614-0251","observed_orcids":["https://orcid.org/0000-0002-5614-0251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiang H","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101671091","display_name":"Shu-Xian Jin","orcid":"https://orcid.org/0000-0001-6620-6990","observed_orcids":["https://orcid.org/0000-0001-6620-6990"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jin S","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.33209638,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/magnetoliposomes","display_name":"magnetoliposomes","score":0.9629999995231628},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/magnetic-nanoparticles","display_name":"magnetic nanoparticles","score":0.8629999756813049},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.7649999856948853},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.765999972820282},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6359999775886536},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.30799999833106995},{"id":"https://openalex.org/keywords/apoptosis-signaling-pathway","display_name":"apoptosis signaling","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.8220000267028809},{"id":"https://openalex.org/keywords/nude-mouse-xenograft","display_name":"nude mouse xenograft","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.854611873626709},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.7776951193809509},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41412073373794556},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3581230640411377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30734360218048096},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1878797709941864},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0659300684928894}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:dovepress.com/18511","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/preclinical-evaluation-of-recombinant-human-ifnalpha2b-containing-magn-peer-reviewed-article-IJN","pdf_url":"https://www.dovepress.com/preclinical-evaluation-of-recombinant-human-ifnalpha2b-containing-magn-peer-reviewed-article-IJN","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:d8010bf037184188a1483eb2a4c97774","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d8010bf037184188a1483eb2a4c97774","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 4533-4550 (2014)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:dovepress.com/18511","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/preclinical-evaluation-of-recombinant-human-ifnalpha2b-containing-magn-peer-reviewed-article-IJN","pdf_url":"https://www.dovepress.com/preclinical-evaluation-of-recombinant-human-ifnalpha2b-containing-magn-peer-reviewed-article-IJN","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322725","display_name":"China Scholarship Council","ror":"https://ror.org/04atp4p48"},{"id":"https://openalex.org/F4320338464","display_name":"Natural Science Foundation of Zhejiang Province","ror":"https://ror.org/01h0zpd94"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382645238.pdf","grobid_xml":"https://content.openalex.org/works/W4382645238.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2133346512","https://openalex.org/W2377562975","https://openalex.org/W4361801573","https://openalex.org/W2945201117","https://openalex.org/W2750065643","https://openalex.org/W3002355528","https://openalex.org/W2885151025","https://openalex.org/W2527364704","https://openalex.org/W7058352368","https://openalex.org/W2607722588"],"abstract_inverted_index":{"Hui":[0],"Ye,1,2":[1],"Jiansong":[2],"Tong,2":[3],"Jianzhang":[4],"Wu,3":[5],"Xia":[6],"Xu,4":[7],"Shenjie":[8],"Wu,5":[9],"Botao":[10],"Tan,6":[11],"Mengjing":[12],"Shi,5":[13],"Jianguang":[14],"Wang,1":[15],"Weibo":[16],"Zhao,5":[17],"Heng":[18],"Jiang,5":[19],"Sha":[20],"Jin5":[21],"1School":[22],"of":[23,33,36,55,61,72,79,159,221,225,230,247,249,259],"Basic":[24],"Medical":[25,28,51,65,68],"Sciences,":[26,66],"Wenzhou":[27,50,67],"University,":[29,52,58,69,75],"Wenzhou,":[30,53,70],"People\u2019s":[31,77],"Republic":[32,78],"China;":[34],"2Department":[35],"Cellular":[37],"and":[38,113,119,125,188,196,211],"Molecular":[39],"Biology,":[40],"Scripps":[41],"Research":[42],"Institute,":[43],"La":[44],"Jolla,":[45],"CA,":[46],"USA;":[47],"3Pharmaceutical":[48],"College,":[49],"4School":[54],"Medicine,":[56,73],"Zhejiang":[57],"Hangzhou,":[59],"5School":[60],"the":[62,153,175,179,219,228,242,250],"1st":[63],"Clinical":[64],"6School":[71],"Lishui":[74],"Lishui,":[76],"China":[80],"Abstract:":[81],"Magnetoliposomes":[82],"are":[83],"phospholipid":[84],"vesicles":[85],"encapsulating":[86],"magnetic":[87,205],"nanoparticles":[88,180],"that":[89,133,148,165,178,192,238,248,256],"can":[90],"be":[91,182],"used":[92],"to":[93,208,245,265],"encapsulate":[94],"therapeutic":[95,120],"drugs":[96],"for":[97],"delivery":[98],"into":[99],"specific":[100],"organs.":[101],"Herein,":[102],"we":[103],"developed":[104],"magnetoliposomes":[105],"containing":[106],"recombinant":[107,273],"human":[108,234,270,274],"IFN\u03b12b,":[109],"designated":[110],"as":[111],"MIL,":[112],"evaluated":[114],"this":[115],"combination\u2019s":[116],"biological":[117],"safety":[118],"effect":[121,170],"on":[122,171],"both":[123],"cellular":[124],"animal":[126],"hepatocellular":[127,235,277],"carcinoma":[128,236,278],"models.":[129],"Our":[130],"data":[131],"showed":[132,147,164,191,237],"MIL":[134,149,166,193,215,226,239],"neither":[135],"hemolyzed":[136],"erythrocytes":[137],"nor":[138],"affected":[139],"platelet-aggregation":[140],"rates":[141],"in":[142,200,227],"blood.":[143],"Nitroblue":[144],"tetrazolium-reducing":[145],"testing":[146,162],"did":[150],"not":[151],"change":[152],"absolute":[154],"numbers":[155],"or":[156,261],"phagocytic":[157],"activities":[158],"leukocytes.":[160],"Acute-toxicity":[161],"also":[163,216],"had":[167],"no":[168],"devastating":[169],"mice":[172,232],"behaviors.":[173],"All":[174],"results":[176],"indicated":[177],"could":[181],"a":[183,204],"safe":[184],"biomaterial.":[185],"Pharmacokinetic":[186],"analysis":[187],"tissue-distribution":[189],"studies":[190,254],"maintained":[194],"stable":[195],"sustained":[197],"drug":[198],"concentrations":[199],"target":[201],"organs":[202],"under":[203],"field,":[206],"helped":[207],"increase":[209],"bioavailability,":[210],"reduced":[212,241],"administration":[213],"time.":[214],"dramatically":[217],"inhibited":[218],"growth":[220,257],"hepatoma":[222],"cells.":[223],"Targeting":[224],"livers":[229],"nude":[231],"bearing":[233],"significantly":[240],"tumor":[243],"size":[244],"38%":[246],"control":[251],"group.":[252],"Further":[253],"proved":[255],"inhibition":[258],"cells":[260],"tumors":[262],"was":[263],"due":[264],"apoptosis-signaling":[266],"pathway":[267],"activation":[268],"by":[269],"IFN\u03b12b.":[271],"Keywords:":[272],"interferon-\u03b12b,":[275],"magnetoliposome,":[276]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-15T10:00:46.086208","created_date":"2023-07-01T00:00:00"}